iRGD as a tumor-penetrating peptide for cancer therapy
Hong Yin(Soochow University), Junnian Zheng(Xuzhou Medical College), Jǐnjīng Xǔ(Nanjing Medical University), Qing Zhang(South China University of Technology), Jie Yang(Xuzhou Medical College), Haiyu Wang(Leiden University Medical Center)
Cited by 74
Related Papers
Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment
|Oncotarget|2018|217
DNA damage response – A double-edged sword in cancer prevention and cancer therapy
|Cancer Letters|2014|189
Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models
|Journal of Immunology Research|2018|152
HAb18G/CD147 Functions in Invasion and Metastasis of Hepatocellular Carcinoma
|Molecular Cancer Research|2007|148
The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects
|Frontiers in Immunology|2024|136